• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    More On VRSEF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Verisante Technology, Inc. (VRSEF)

    -Other OTC
    0.09 0.00(0.00%) Jul 2, 12:22PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Verisante Technology, Inc.
    2309 West 41st Avenue
    Suite 306
    Vancouver, BC V6M 2A3
    Canada - Map
    Phone: 604-605-0507
    Fax: 604-605-0508
    Website: http://www.verisante.com

    Details 
    Index Membership:N/A
    Sector:N/A
    Industry:N/A
    Full Time Employees:N/A

    Business Summary 

    Verisante Technology, Inc., a medical device company, develops and commercializes skin cancer detection systems. The company’s products include Verisante Aura, a spectroscopy system to aid in the detection of various skin cancers, including basal cell carcinoma, squamous cell carcinoma, melanoma, pre-cancerous lesions, and actinic keratosis; and Verisante Core for the detection of other types of cancer, including lung, gastro-intestinal, colorectal, and cervical cancers. It has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology, Inc. in January 2011. Verisante Technology, Inc. was founded in 2006 and is headquartered in Vancouver, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Verisante Technology, Inc.

    Key Executives 
     PayExercised
    Mr. Thomas A. Braun BA, J.D., LLM, 47
    Chief Exec. Officer, Pres, Director, Member of Compensation Committee and Member of Audit Committee
    253.00K0.00
    Ms. Anna Trinh B.Comm LLB, 41
    Chief Financial Officer, Corp. Counsel and Sec.
    134.00K0.00
    Mr. Jason Mangler ,
    Director of Sales
    N/AN/A
    David Kronstein ,
    Exec. Officer
    N/AN/A
    Rizah Bahic ,
    Exec. Officer
    N/AN/A
    Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.